0 Комментарии
0 Поделились
316 Просмотры
0 предпросмотр
Поиск
Знакомьтесь и заводите новых друзей
-
Новости
- ИССЛЕДОВАТЬ
-
Страницы
-
Группы
-
Мероприятия
- Статьи пользователей
- Offers
- Jobs
- Войдите, чтобы отмечать, делиться и комментировать!
- Generic Anti-Cancer Injectables Market to Reach USD 15.4 Billion by 2034 | CAGR 5.2%According to a newly published market research report by 24LifeSciences, global generic anti-cancer injectables market was valued at USD 9.8 billion in 2025 and is projected to reach USD 15.4 billion by 2034, growing at a compound annual growth rate (CAGR) of 5.2% during the forecast period 20262034. Generic anti-cancer injectables are bioequivalent versions of branded oncology drugs...0 Комментарии 0 Поделились 242 Просмотры 0 предпросмотр
- Is Aesthetic Dermatology Becoming Mainstream Across Europe?Executive Summary Europe Aesthetic Dermatology Market Market: Share, Size & Strategic Insights CAGR Value Data Bridge Market Research analyses that the Europe aesthetic dermatology market will grow at a CAGR of 9.7% during the forecast period of 2022 to 2029. This Europe Aesthetic Dermatology Market Market research report is a detailed synopsis on the study of Europe Aesthetic...0 Комментарии 0 Поделились 387 Просмотры 0 предпросмотр
- North America Bupivacaine Liposome Injectable Suspension Market Growth Analysis and Industry Overview to 2031The North America Bupivacaine Liposome Injectable Suspension landscape is experiencing notable expansion, supported by rising surgical volumes and the growing emphasis on effective postoperative pain management. Healthcare systems across the United States and Canada are increasingly prioritizing patient recovery, reduced hospital stays, and minimized opioid use. This has accelerated the...0 Комментарии 0 Поделились 115 Просмотры 0 предпросмотр
- North America Generic Injectables Market: Growth, Trends, and Dynamics Shaping the Future outlook by 2028The North America generic injectables market is witnessing strong expansion, driven by rising demand for cost-effective therapies, increasing chronic disease burden, and a well-established healthcare infrastructure. The region, led by the United States, holds a dominant share in the global market due to high adoption of generics and favorable regulatory frameworks that encourage competition. In...0 Комментарии 0 Поделились 155 Просмотры 0 предпросмотр